HEALTH DISCOVERY COM NPV (HDVY)

0.03
0.00 3.33
OTC
Prev Close 0.03
Open 0.03
Day Low/High 0.03 / 0.03
52 Wk Low/High 0.02 / 0.07
Volume 35.00K
Exchange OTC
Shares Outstanding 271.72B
Market Cap 8.15M
Div & Yield N.A. (N.A)

Latest News

Health Discovery Corporation Issues Update On Challenges To Intel SVM-RFE Patent

Health Discovery Corporation Issues Update On Challenges To Intel SVM-RFE Patent

Health Discovery Corporation (OTCBB: HDVY) has received notification from the United States Patent and Trademark Office that it intends to issue a re-examination certificate to Intel Corporation following completion of...

NeoGenomics Develops And Implements Proprietary Method For Automating And Interpreting Fluorescence In-Situ Hybridization Test Data

NeoGenomics Develops And Implements Proprietary Method For Automating And Interpreting Fluorescence In-Situ Hybridization Test Data

Company Applies for Utility Patent on Methodology and Related Software

Retinalyze, LLC Signs Licensing Agreement For Vision Plan Reimbursement

Retinalyze, LLC Signs Licensing Agreement For Vision Plan Reimbursement

Retinalize, LLC is pleased to announce that it has signed an agreement to begin using the Retinalytics SVM TM analysis technology for Vision Care Direct and associated vision health and wellness plans.

Retinalyze, LLC Begins Enrolling Ophthalmology Practices

Retinalyze, LLC Begins Enrolling Ophthalmology Practices

Retinalize, LLC is pleased to announce that it has signed contracts with several large multi-physician Ophthalmology groups in Florida to begin using the Retinalytics SVM analysis technology to assist physicians in the...

Health Discovery Corporation’s Popular MelApp Featured In Men's Health Magazine

Health Discovery Corporation’s Popular MelApp Featured In Men's Health Magazine

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment is featured in this month's Men's Health...

Retinalyze, LLC Enters Into An Exclusive Agreement With NATIONAL EYEPA COALITION

Retinalyze, LLC Enters Into An Exclusive Agreement With NATIONAL EYEPA COALITION

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, and Doctors Optimal Formula LLC , a physician...

Health Discovery Corporation And Doctors Optimal Formula Launching Retinalyze Analytics For Detection Of Macular Degeneration

Health Discovery Corporation And Doctors Optimal Formula Launching Retinalyze Analytics For Detection Of Macular Degeneration

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques and pattern recognition technology (SVM) for personalized medicine, and...

Health Discovery Corporation Debuts MelApp 2.0 For IPhone

Health Discovery Corporation Debuts MelApp 2.0 For IPhone

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched the first SVM-based image analysis iPhone app for melanoma risk assessment, MelApp, today debuts MelApp 2.

Health Discovery Corporation Launches Android Version Of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

Health Discovery Corporation Launches Android Version Of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, today debuts its popular MelApp mobile app...

MelApp For IPhone Application Receives Record Downloads From National Magazine Coverage

MelApp For IPhone Application Receives Record Downloads From National Magazine Coverage

Named one of the “ Top 10 Apps That Could Save Your Life” in the Jan.

Health Discovery Corporation Enters Into Worldwide Licensing Agreement With NeoGenomics

Health Discovery Corporation Enters Into Worldwide Licensing Agreement With NeoGenomics

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licensing...

Health Discovery Corporation Appoints John Hadden Senior Vice President Of National And International Business Development

Health Discovery Corporation (OTCBB: HDVY) today announced the appointment of John R.

Health Discovery Corporation And Doctors Optimal Formula To Develop World’s First SVM-Based Retinal Image Analysis For Retinal Disease Assessment And Treatment Protocol

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has signed a Letter of Intent with anti-aging,...

Health Discovery Corporation Issues Update On U.S. And International Developments Relating To Its SVM-RFE Technology Patents

Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that it has recently received notices of allowance in two of its patent applications covering the Company’s SVM-RFE technology.

Health Discovery Corporation Issues Update On Developments Relating To Intel RFE-SVM Patent

Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that a request for reexamination of Intel Corporation’s U.

Health Discovery Corporation Announces Issuance Of First Patent Covering Prostate Cancer Biomarkers

Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that the United States Patent and Trademark Office has issued the first of what the Company expects to be several patents covering methods to screen for...

MelApp IPhone Application By Health Discovery Corporation Continues Global Success

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that recently launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, reports great adoption among...

Health Discovery Corporation Announces Progress In Its Efforts To Cancel Intel Patent Claiming The RFE-SVM Method

Health Discovery Corporation (HDC) (OTCBB: HDVY) is pleased to announce that its continuation patent application with claims directed to its RFE-SVM method, which was filed in November 2010, has already been indicated...

MelApp IPhone Application By Health Discovery Corporation Continues Global Success In Its Second Week Of Sales

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics company that uses patent protected advanced mathematical techniques for personalized medicine, reports on second week traction of its game-changing...

Health Discovery Corporation Sees Consumer “App” Market As Viable Channel To Leverage Its Intellectual Property Portfolio

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics company that uses patent protected advanced mathematical techniques for personalized medicine, announces its Safe Health App Suite for the rapidly...

MelApp Logo (Graphic: Business Wire)

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics company that uses patent protected advanced mathematical techniques for personalized medicine, says its game-changing iPhone app, MelApp, has the...

MelApp Logo

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics company that uses patent protected advanced mathematical techniques for personalized medicine, places its vast expertise in the palms of ...

Health Discovery Corporation Not Source For Recent Press Release

A press release disseminated by PRNewswire on or about April 20, 2011 reporting comments made by securities analyst Howard Stillman regarding Health Discovery Corporation (OTCBB: HDVY) (HDC) incorrectly stated that HDC...

Health Discovery Corporation’s President, Thomas Gallagher, Steps Down

Thomas Gallagher, President, Chief Operating Officer and General Counsel of Health Discovery Corporation (OTCBB: HDVY) (HDC), informed the Board of Directors of his intention to pursue a new opportunity.

Health Discovery Corporation Awarded A $244,479.25 Qualifying Therapeutic Discovery Project (QTDP) Grant Under The Patient Protection And Affordable Care Act Of 2010

Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that it has been awarded $244,479.